Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 2
Submit an article Journal homepage
146
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Imaging minimal residual disease evaluation in multiple myeloma using [18F]FDG PET/MRI

Gregorio Barilàa Hematology Unit, Azienda ULSS3 Serenissima, Ospedale dell’Angelo, Venezia-Mestre, ItalyORCID Iconhttps://orcid.org/0000-0003-3430-6115View further author information
ORCID Icon,
Filippo Crimìb Department of Medicine (DIMED), Institute of Radiology, Padua University School of Medicine, Padova, ItalyView further author information
,
Massimiliano Arangio Febboc Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua University School of Medicine, Padova, ItalyView further author information
,
Laura Pavanc Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua University School of Medicine, Padova, ItalyView further author information
,
Susanna Vedovatod Hematology Unit, Ospedale san Bortolo, Vicenza, ItalyView further author information
,
Giulio Cabrelleb Department of Medicine (DIMED), Institute of Radiology, Padua University School of Medicine, Padova, ItalyView further author information
,
Chiara Zanonb Department of Medicine (DIMED), Institute of Radiology, Padua University School of Medicine, Padova, ItalyView further author information
,
Cristina Campie Department of Mathematics (DIMA), University of Genoa, Genoa, ItalyView further author information
,
Diego Cecchinf Department of Medicine (DIMED), Nuclear Medicine Unit, School of Medicine, University Hospital of Padova, Padova, ItalyView further author information
,
Pietro Zucchettaf Department of Medicine (DIMED), Nuclear Medicine Unit, School of Medicine, University Hospital of Padova, Padova, ItalyView further author information
,
Carmelo Lacognatab Department of Medicine (DIMED), Institute of Radiology, Padua University School of Medicine, Padova, ItalyView further author information
,
Gianpietro Semenzatoc Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua University School of Medicine, Padova, ItalyView further author information
&
Renato Zambelloc Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua University School of Medicine, Padova, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 503-506 | Received 13 Aug 2022, Accepted 22 Oct 2022, Published online: 16 Nov 2022

References

  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–e548.
  • Kumar S, Paiva B, Anderson KC, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–e346.
  • Zamagni E, Nanni C, Mancuso K, et al. PET/CT improves the definition of complete response and allows to detect otherwise unidentifiable skeletal progression in multiple myeloma. Clin Cancer Res. 2015;21(19):4384–4390.
  • Moreau P, Attal M, Caillot D, et al. Prospective evaluation of magnetic resonance imaging and [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM/DFCI 2009 trial: results of the IMAJEM study. J Clin Oncol. 2017;35(25):2911–2918.
  • Zamagni E, Nanni C, Dozza L, et al. Standardization of (18)F-FDG-PET/CT according to deauville criteria for metabolic complete response definition in newly diagnosed multiple myeloma. J Clin Oncol. 2021;39(2):116–125.
  • Lacognata C, Crimi F, Guolo A, et al. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol. 2017;72(10):850–857.
  • Pawlyn C, Fowkes L, Otero S, et al. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia. 2016;30(6):1446–1448.
  • Messiou C, Hillengass J, Delorme S, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. 2019;291(1):5–13.
  • Rasche L, Alapat D, Kumar M, et al. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma. Leukemia. 2019;33(7):1713–1722.
  • Zambello R, Crimi F, Lico A, et al. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI. Ann Hematol. 2019;98(3):679–689.
  • Rasche L, Chavan SS, Stephens OW, et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017;8(1):268.
  • Cavo M, Terpos E, Nanni C, et al. Role of (18)F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18(4):e206–e217.
  • Rasche L, Angtuaco E, McDonald JE, et al. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood. 2017;130(1):30–34.
  • Belotti A, Ribolla R, Cancelli V, et al. Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry. Cancer Med. 2021;10(17):5859–5865.
  • Messiou C, Porta N, Sharma B, et al. Prospective evaluation of whole-body MRI versus FDG PET/CT for lesion detection in participants with myeloma. Radiol Imaging Cancer. 2021;3(5):e210048.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.